Morphological abnormalities in the brains of estrogen receptor β knockout mice

Estrogen receptor β (ERβ) is expressed at high levels in both neurons and glial cells of the central nervous system. The development of ERβ knockout (BERKO) mice has provided a model to study the function of this nuclear receptor in the brain. We have found that the brains of BERKO mice show several morphological abnormalities. There is a regional neuronal hypocellularity in the brain, with a severe neuronal deficit in the somatosensory cortex, especially layers II, III, IV, and V, and a remarkable proliferation of astroglial cells in the limbic system but not in the cortex. These abnormalities are evident as early as 2 mo of age in BERKO mice. As BERKO mice age, the neuronal deficit becomes more pronounced, and, by 2 yr of age, there is degeneration of neuronal cell bodies throughout the brain. This is particularly evident in the substantia nigra. We conclude that ERβ is necessary for neuronal survival and speculate that this gene could have an important influence on the development of degenerative diseases of the central nervous system, such as Alzheimer's disease and Parkinson's disease, as well as those resulting from trauma and stroke in the brain.

[1]  I. Merchenthaler,et al.  Estrogen binding and estrogen receptor characterization (ERα and ERβ) in the cholinergic neurons of the rat basal forebrain , 2000, Neuroscience.

[2]  H C Liu,et al.  Effects of estrogen on cognition, mood, and cerebral blood flow in AD , 2000, Neurology.

[3]  A. Hofman,et al.  Estrogen use and early onset Alzheimer's disease: a population-based study , 1999, Journal of neurology, neurosurgery, and psychiatry.

[4]  M. Kraut,et al.  Estrogen Replacement Therapy and MRI‐Demonstrated Cerebral Infarcts, White Matter Changes, and Brain Atrophy in Older Women: The Cardiovascular Health Study , 2000, Journal of the American Geriatrics Society.

[5]  O. Zanetti,et al.  Menopause and estrogen deficiency as a risk factor in dementing illness: hypothesis on the biological basis. , 1999, Maturitas.

[6]  A. Maggi,et al.  Estrogen Receptor Is Expressed in Different Types of Glial Cells in Culture , 1994, Journal of neurochemistry.

[7]  P. Shughrue,et al.  Comparative distribution of estrogen receptor‐α and ‐β mRNA in the rat central nervous system , 1997, The Journal of comparative neurology.

[8]  Anthony Gamst,et al.  Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease: A Randomized Controlled Trial , 2000 .

[9]  H. Urbanski,et al.  Distribution of estrogen receptor beta (ERbeta) mRNA in hypothalamus, midbrain and temporal lobe of spayed macaque: continued expression with hormone replacement. , 2000, Brain research. Molecular brain research.

[10]  L. Garcia-Segura,et al.  Role of astroglia in estrogen regulation of synaptic plasticity and brain repair. , 1999, Journal of neurobiology.

[11]  Í. Azcoitia,et al.  Localization of estrogen receptor β‐immunoreactivity in astrocytes of the adult rat brain , 1999, Glia.

[12]  B L Miller,et al.  Estrogen for Alzheimer’s disease in women , 2000, Neurology.

[13]  B. McEwen,et al.  Estrogen actions in the central nervous system. , 1999, Endocrine reviews.

[14]  R. DeTeresa,et al.  Some morphometric aspects of the brain in senile dementia of the alzheimer type , 1981, Annals of neurology.

[15]  C. Beyer Estrogen and the developing mammalian brain , 1999, Anatomy and Embryology.

[16]  J. Mong,et al.  Steroid-induced developmental plasticity in hypothalamic astrocytes: implications for synaptic patterning. , 1999, Journal of neurobiology.

[17]  J. Mong,et al.  Gonadal Steroids Promote Glial Differentiation and Alter Neuronal Morphology in the Developing Hypothalamus in a Regionally Specific Manner , 1999, The Journal of Neuroscience.

[18]  I. Skoog Status of Risk Factors for Vascular Dementia , 1998, Neuroepidemiology.

[19]  G. Fink,et al.  Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine(2A) receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement. , 1999, Brain research. Molecular brain research.

[20]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[21]  A. Maggi,et al.  Dopaminergic Phenotype Induced by Oestrogens in a Human Neuroblastoma Cell Line , 1997, The European journal of neuroscience.

[22]  C Labrie,et al.  Expression and neuropeptidergic characterization of estrogen receptors (ERalpha and ERbeta) throughout the rat brain: anatomical evidence of distinct roles of each subtype. , 1998, Journal of neurobiology.

[23]  K. Kompoliti Estrogen and movement disorders. , 1999, Clinical neuropharmacology.

[24]  E G Tangalos,et al.  Postmenopausal estrogen replacement therapy and risk of AD , 1999, Neurology.

[25]  L. Doncarlos,et al.  Neuroprotection by estradiol , 2001, Progress in Neurobiology.

[26]  E. Rissman,et al.  Distribution of estrogen receptor-beta-like immunoreactivity in rat forebrain. , 1997, Neuroendocrinology.

[27]  J. Gustafsson,et al.  Generation and reproductive phenotypes of mice lacking estrogen receptor beta. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[28]  N. R. Nichols,et al.  Glial responses to steroids as markers of brain aging. , 1999, Journal of neurobiology.

[29]  G. Mor,et al.  Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system. , 2000, Journal of neurobiology.